AGP Picks
View all

Healthy Living Europe
Provided by AGP

Healthy Living Europe: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthy Living Europe.

May 2026

Mo Tu We Th Fr Sa Su
1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31

June 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

July 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

Press releases published on June 5, 2026

DBV Technologies to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference
Jun. 5, 2026

DBV Technologies to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference

Indeterminate GlobeNewswire
DBV Technologies participera à la 47ème conférence annuelle Global Healthcare organisée par Goldman Sachs
Jun. 5, 2026

DBV Technologies participera à la 47ème conférence annuelle Global Healthcare organisée par Goldman Sachs

Indeterminate GlobeNewswire
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Jun. 5, 2026

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Three Reputable Eyewash Station Manufacturers in China 2026: Boosting Industrial Emergency Safety Compliance
Jun. 5, 2026

Three Reputable Eyewash Station Manufacturers in China 2026: Boosting Industrial Emergency Safety Compliance

Indeterminate EIN Presswire
Banner Health appoints Dr. John Rares Almasan as senior vice president, chief AI, data and infrastructure officer
Jun. 5, 2026

Banner Health appoints Dr. John Rares Almasan as senior vice president, chief AI, data and infrastructure officer

Indeterminate GlobeNewswire
Voting Rights and Shares Capital of the Company
Jun. 5, 2026

Voting Rights and Shares Capital of the Company

Indeterminate GlobeNewswire
Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social
Jun. 5, 2026

Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social

Indeterminate GlobeNewswire
Memocept Under Investigation: Shocking Memocept Brain Support Customer Complaints, Ingredient Claims, Effectiveness Questions, and Serious Side Effect Risks Examined
Jun. 5, 2026

Memocept Under Investigation: Shocking Memocept Brain Support Customer Complaints, Ingredient Claims, Effectiveness Questions, and Serious Side Effect Risks Examined

Indeterminate GlobeNewswire
HRC Technology Solutions LLC Expands Scope and Is Successfully Reappraised at CMMI® Services Maturity Level 3, Reinforcing Its AI-Driven Operating Model
Jun. 5, 2026

HRC Technology Solutions LLC Expands Scope and Is Successfully Reappraised at CMMI® Services Maturity Level 3, Reinforcing Its AI-Driven Operating Model

Indeterminate GlobeNewswire
Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Jun. 5, 2026

Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Shattuck Labs to Host Investor Call and Webcast on Phase 1 Clinical Data of SL-325, a Potentially First-in-Class DR3 Blocking Antibody, and Pipeline Update on June 8
Jun. 5, 2026

Shattuck Labs to Host Investor Call and Webcast on Phase 1 Clinical Data of SL-325, a Potentially First-in-Class DR3 Blocking Antibody, and Pipeline Update on June 8

Indeterminate GlobeNewswire
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Jun. 5, 2026

Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Structure Therapeutics Announces Publication in Nature Medicine Highlighting Phase 2b ACCESS Program of Aleniglipron for Obesity
Jun. 5, 2026

Structure Therapeutics Announces Publication in Nature Medicine Highlighting Phase 2b ACCESS Program of Aleniglipron for Obesity

Indeterminate GlobeNewswire
Spyre Therapeutics Announces Grants of Inducement Awards
Jun. 5, 2026

Spyre Therapeutics Announces Grants of Inducement Awards

Indeterminate GlobeNewswire
Jade Biosciences Announces Closing of Public Offering of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
Jun. 5, 2026

Jade Biosciences Announces Closing of Public Offering of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

Indeterminate GlobeNewswire
Grey Matters Closes First Tranche of $500,000 of its Private Placement Financing
Jun. 5, 2026

Grey Matters Closes First Tranche of $500,000 of its Private Placement Financing

Indeterminate GlobeNewswire
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Jun. 5, 2026

Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Rivus Pharmaceuticals Announces Preclinical Data for RV-8451, a Muscle-Preserving, Oral GLP-1, at ADA 2026 Scientific Sessions
Jun. 5, 2026

Rivus Pharmaceuticals Announces Preclinical Data for RV-8451, a Muscle-Preserving, Oral GLP-1, at ADA 2026 Scientific Sessions

Indeterminate GlobeNewswire
WuXi AppTec Accelerates Global Manufacturing Expansion to Meet Rising Customer Demand
Jun. 5, 2026

WuXi AppTec Accelerates Global Manufacturing Expansion to Meet Rising Customer Demand

Indeterminate EIN Presswire
Growing Mental Health Crisis in Ireland Driving More People to Seek Private Treatment Abroad
Jun. 5, 2026

Growing Mental Health Crisis in Ireland Driving More People to Seek Private Treatment Abroad

Indeterminate EIN Presswire
Show More

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Healthy Living Europe

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.